@article{7cdede08e6e443808c7696162542a018,
title = "The ZNF217 biomarker predicts low-and high-risk oncotype DX{\textregistered} recurrence score in ER-positive invasive breast cancers",
keywords = "Biomarker, Breast cancer, Estrogen-receptor positive, Expression, Oncotype DX{\textregistered}, ZNF217",
author = "Cohen, {Pascale A.} and Olivier Loudig and Christina Liu and Joseph Albanese and Susan Fineberg",
note = "Funding Information: The French-American Fulbright Program and the French Ministry of Higher Education, Research and Innovation supported PC. This work was supported by the French Ligue contre le cancer (committees 71 and 42). We thank Dr. B. Manship for critical reading of the manuscript.",
year = "2019",
doi = "10.3389/fphar.2019.00524",
language = "English (US)",
volume = "10",
journal = "Frontiers in Pharmacology",
issn = "1663-9812",
publisher = "Frontiers Media S. A.",
number = "MAY",
}